BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10704232)

  • 1. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.
    Morillas M; Vanik DL; Surewicz WK
    Biochemistry; 2001 Jun; 40(23):6982-7. PubMed ID: 11389614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form.
    Hosszu LL; Tattum MH; Jones S; Trevitt CR; Wells MA; Waltho JP; Collinge J; Jackson GS; Clarke AR
    Biochemistry; 2010 Oct; 49(40):8729-38. PubMed ID: 20718410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI; Thirumalai D
    Biophys J; 2002 Sep; 83(3):1268-80. PubMed ID: 12202354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA and CuCl2 induced conformational changes of the recombinant ovine prion protein.
    Liu M; Yu S; Yang J; Yin X; Zhao D
    Mol Cell Biochem; 2007 Jan; 294(1-2):197-203. PubMed ID: 16855791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
    Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
    Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the prion protein using chemical synthesis.
    Ball HL; King DS; Cohen FE; Prusiner SB; Baldwin MA
    J Pept Res; 2001 Nov; 58(5):357-74. PubMed ID: 11892845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
    Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
    J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
    Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
    Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local structural plasticity of the prion protein. Analysis of NMR relaxation dynamics.
    Viles JH; Donne D; Kroon G; Prusiner SB; Cohen FE; Dyson HJ; Wright PE
    Biochemistry; 2001 Mar; 40(9):2743-53. PubMed ID: 11258885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
    Zou WQ; Cashman NR
    J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.